About UsProductsNewsClinical TrialCorporate RelationsResources

Recent Press Releases:

Upcoming Events

OFFICIAL RELEASE

Dr. Stephen R. Ash Receives Lifetime Achievement Award at the 4th Annual ASDIN Scientific Meeting in Salt Lake City

Second Recipient and Founding ASDIN Member Recognized for “Many” Talents and Contributions to Field of Interventional Nephrology

FEBRUARY 11, 2008 7:45 AM EST (Lafayette, Indiana) - - - The Gerald A. Beathard Lifetime Achievement Award was awarded to Dr. Stephen R. Ash, MD on Friday, February 8th at the 4th Annual ASDIN Scientific Meeting. Dr. Ash became the 2nd recipient of the award and was graciously honored by his colleague and friend, Dr. Gerald Beathard for whom the award was named. Dr. Beathard reiterated the many talents Dr. Ash has demonstrated throughout his career, including – being an excellent practitioner and surgeon, authoring more than 30 patents and developing significant medical devices as well as being intricately involved in the creation, growth and success of both the ASDIN and ASAIO (American Society of Artificial Internal Organs) to name a few.

“It was very flattering and humbling receiving the Gerald A. Beathard Lifetime Achievement Award at ASDIN this weekend," said Dr. Ash as he reflected on the event. "I appreciate the society and my peers recognizing the contributions I have been fortunate to make throughout my career. What a neat experience to receive the award from the person who it was actually named after. The ASDIN and Annual Scientific Meeting continue to make significant strides and it is truly a pleasure to be a part of this group.”

In addition to receiving the award, Dr. Ash, Board Chairman and Director of R&D at Ash Access Technology (AshAccess.com), renowned as the inventor of the original split tip dialysis catheter, presented data from a United States preliminary clinical study of his latest hemodialysis catheter innovation - Centros™. The distal end of the Centros™ catheter has a unique curved configuration; is placed in the lower third of the superior vena cava (SVC) instead of the right atrium and its curved tips keep the ports of the catheter centered away from the vein walls. The United States Food and Drug Administration granted its 510(k) clearance for Centros™ in June 2007. Ash Access Technology, Inc agreed to give exclusive worldwide rights to manufacture and market the Centros™ dialysis catheter to Queensbury, NY-based AngioDynamics.


About Ash Access Technlogy, Inc.

Ash Access Technology, Inc. is a privately held specialty pharmaceutical / medical device company focused on the development and commercialization of proprietary products and devices to improve vascular access outcomes. The Company's diverse product portfolio includes innovative hemodialysis and peritoneal dialysis catheters and a unique antimicrobial / antithrombotic solution, ZuragenTM, being developed for the prevention and treatment of catheter related bloodstream infection (CRBSI). Ash Access Technology is located in Lafayette, Indiana in the INOK Business Center.

Safe Harbor

The statements made in this document contain certain forward-looking statements that involve a number of risks and uncertainties. Words such as "expects," "intends," "anticipates," "plans," "believes," "seeks," "estimates," or variations of such words and similar expressions, are intended to identify such forward-looking statements. Investors are cautioned that actual events or results may differ from the Company's expectations. In addition to the matters described above, the ability of the Company to develop its products, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from group purchasing organizations and competition, as well as other risk factors may affect the actual results achieved by the Company.